|
|
DGAPNews: Kadimastem
Kadimastem Receives US Patent For Amyotrophic Lateral Sclerosis ALS Treatment
09.08.2022 / 13:00 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: Kadimastem
Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement Towards the Potential Licensing of “Immune Evasive” Cells
08.06.2022 / 13:00
The issuer is solely responsible for the content of this announcement.
If the feasibility study is successful, it would be a significant step... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: Kadimastem
Kadimastem Awarded Patent in Japan for AstroRx® For ALS and Drug Screening
30.05.2022 / 15:10
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: Kadimastem
Kadimastem Expands R&D Program to Include Multiple Sclerosis
18.05.2022 / 13:00
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: Kadimastem
Kadimastem Receives Grant for a Total Budget of NIS 10 Million $3.1 million from the Israeli Innovation Authority
03.03.2022 / 14:05
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: Kadimastem
Kadimastem Announces the Approval of a 4M NIS $1.29M Budget from the Israel Innovation Authority
13.12.2021 / 13:00
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: Kadimastem
Kadimastem Raises $5 million In Private Placement
26.10.2021 / 07:49
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
